A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Rizatriptan (Primary)
- Indications Menstrual migraine
- Focus Registrational; Therapeutic Use
- Sponsors Merck & Co
- 28 Jun 2007 Results were reported at the 13th Congress of the International Headache Society.
- 21 Oct 2005 New trial record.